Reposted - may explain the large BID versus ASK-->" I don't post garbage. They are facts that Pfizer and USC Keck have been working together since 2013 and Pfizer has exclusive option to start clinical trials on anything promising.
Then Medipharm joined the picture in 2015.
In 2023 Medipharm shipped clinical trial material to USC Keck with approval by the DEA and funded by the NIH.
But what I see is there are a handful of people on this board who think they run it and want to control the narrative and keep things in a negative tone by 'bashing' other posters.
I'm still very optimistic that this company will show profits in October reporting and maybe a reason why they suddenly payed off the last piece of debt.
If you have facts to bring to this forum then that's great but don't bash other people because it makes you look desperate instead of fact based investor. "